Non-clinical characterization of the disposition of EMA401, a novel small molecule angiotensin II type 2 receptor (AT2R) antagonist

Murgasova, R; Carreras, ET; Suetterlin-Hachmann, M; Torrao, LRD; Kittelmann, M; Alexandra, V; Fredenhagen, A

Murgasova, R (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, WSJ 153-1-16 POB, CH-4002 Basel, Switzerland.

BIOPHARMACEUTICS & DRUG DISPOSITION, 2020; 41 (4-5): 166

Abstract

EMA401, (the S-enantiomer of 5-(benzyloxy)-2-(2,2-diphenylacetyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid), also known as Olodanrig......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索